Skip to main content
. 2023 Nov 17;11(11):23259671231210035. doi: 10.1177/23259671231210035

Table 4.

Results of Linear Mixed-Effects Models for Primary Outcomes (MRI T2* and Graft Volume) a

BTB Autograft: T2* BTB Autograft: Volume HS Autograft: T2* HS Autograft: Volume
Estimate
(95% CI)
P Estimate
(95% CI)
P Estimate
(95% CI)
P Estimate
(95% CI)
P
(Intercept) 9.90
(8.99 to 10.82)
<.001 2209.1
(1684.5 to 2733.6)
<.001 10.63
(9.54 to 11.73)
<.001 3187.13
(2636.1 to 3738.2)
<.001
Time: 6 mo 0.52
(−0.05 to 1.09)
.074 217.8
(14.7 to 421.0)
.036 0.59
(−0.16 to 1.33)
.119 118.49
(−223.3 to 460.2)
.489
Time: 9 mo 0.77
(0.13 to 1.40)
.019 144.5
(−150 to 439.1)
.328 0.61
(−0.35 to 1.57)
.205 39.16
(−194.7 to 273)
.738
Time: 12 mo 0.62
(0.01 to 1.22)
.046 308.1
(−35.9 to 652.1)
.078 0.52
(−0.30 to 1.34)
.207 1.19
(−462.5 to 464.9)
.996
Group: intervention −0.63
(−1.89 to 0.63)
.309 135.1
(−606 to 876.1)
.706 −0.89
(−2.17 to 0.39)
.162 −395.81
(−11,141.1 to 351.5)
.280
a

BTB autograft: 20 patients, 69 MRIs; HS autograft: 20 patients, 72 MRIs. Bold P values indicate statistical significance (P < .05). BTB, bone–patellar tendon–bone; HS, hamstring; MRI, magnetic resonance imaging.